Personalis Inc (PSNL)
Healthcare
Diagnostics & Research
13.50 $
+2.4%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +24.2% | +277.5% | +55.7% | +62.0% | -26.2% | -23.1% | +20.1% | +23.6% | |
| – | +10.6% | +372.2% | +58.1% | +44.2% | -37.2% | -26.5% | +38.3% | +32.0% | |
| – | -12.7% | +178.8% | +24.5% | +54.1% | -15.6% | -36.1% | +60.4% | +35.9% | |
| – | -12.7% | +549.8% | +58.5% | +41.2% | -41.6% | -31.9% | +62.0% | +29.7% | |
| – | +130.1% | -26.0% | +92.4% | +190.9% | -9.9% | +6.5% | -54.1% | +99.1% | |
| – | +159.6% | -33.3% | +87.9% | +52.6% | +56.4% | -11.3% | -29.8% | +54.5% | |
| – | +80.6% | +39.3% | -25.8% | +66.0% | +215.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +17.4% | -65.8% | -1.4% | +72.8% | -13.5% | +28.3% | -29.6% | +8.4% | |
| – | +18.1% | -13.6% | -18.7% | -22.9% | +5.8% | +42.6% | -34.1% | +27.3% | |
| – | -71.5% | -72.8% | +79.6% | +126.3% | +37.5% | +23.6% | -0.4% | -13.7% | |
| – | +62.7% | +11.8% | +13.1% | +11.1% | +39.4% | +16.1% | -57.1% | +103.0% | |
| – | +133.9% | – | – | – | – | – | – | – | |
| – | – | – | +82.7% | +59.2% | -29.7% | -40.7% | +56.8% | +28.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -17.2% | +90.9% | +27.7% | +4.1% | +5.4% | +23.0% | +50.6% |
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.